Search headlines

Clover Health (CLOV) Stock Looks Reasonable Despite New 5 Star Ratings

Clover Health Investments has seen sharp swings in its share price in recent years, and the stock closed at US$4.79 most recently. With the business in the spotlight after new Medicare plan ratings, the question for investors is whether that price can be explained by its sales. The stock has delivered a very large 3 year return of about 365.0%, which puts a lot of weight on whether current revenue levels and future top line potential can support today’s valuation. Clover Health’s Medicare...

Oct 10 • 10:32 PM EDT • Health • simplywall.st